日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases

结合无细胞DNA片段组和肿瘤总体积可改善结直肠癌肝转移患者的预后和肿瘤反应评估

Crnovrsanin, Nerma; Zeeuw, J Michiel; Ali, Mahsoem; Kemna, Ruby; Alipanahi, Bahar; Lumbard, Keith; Skidmore, Zachary L; Rinaldi, Lorenzo; van 't Erve, Iris; Wesdorp, Nina J; Huiskens, Joost; van Steijn, Denise; van Waesberghe, Jan Hein; van den Bergh, Janneke; Nota, Irena; Moos, Shira; Bond, Marinde J G; Meiqari, Lana; Huitink, Iris; Giovannetti, Elisa; Stoker, Jaap; Verpalen, Inez; van den Broek, Daan; Meijer, Gerrit A; Swijnenburg, Rutger-Jan; Punt, Cornelis J A; Scharpf, Robert B; Leal, Alessandro; Dracopoli, Nicholas C; Velculescu, Victor E; Kok, Niels F M; Kazemier, Geert; Fijneman, Remond J A

Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy

肿瘤间质比值在术后循环肿瘤DNA和pTN分期的基础上,对接受辅助化疗的III期结肠癌患者进行风险分层的附加价值

Franken, I A; Heilijgers, F; Bakker, M-C E; Rubio-Alarcón, C; van der Baan, F H; Lemmens, M; Diemen, P Delis-van; Sausen, M; Meijer, G A; Koopman, M; Vink, G R; Fijneman, R J A; Mesker, W E; Roodhart, J M L

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS)

促进液体活检在临床实践中的应用:欧洲液体活检学会 (ELBS) 2024 年会议报告

Pantel, Klaus; Alix-Panabières, Catherine; Hofman, Paul; Stoecklein, Nikolas H; Lu, Yong-Jie; Lianidou, Evi; Giacomini, Patrizio; Koch, Claudia; de Jager, Vincent; Deans, Zandra C; Fairley, Jennifer; Patton, Simon J; Toledo, Rodrigo A; Schuuring, Ed; Heitzer, Ellen; Hendrix, An; Ricklefs, Franz Lennard; Thakur, Basant Kumar; von Bubnoff, Nikolas; Pierga, Jean-Yves; Gebhardt, Christoffer; Andersen, Claus Lindbjerg; Fijneman, Remond; Malats, Núria; Hallermayr, Ariane; Chelala, Claude; Joosse, Simon A; Ciliberto, Gennaro

Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study

III期结肠癌患者循环肿瘤DNA:多中心前瞻性PROVENC3研究

Rubio-Alarcón, Carmen; Georgiadis, Andrew; Franken, Ingrid A; Wang, Haoyue; van Nassau, Sietske C M W; Schraa, Suzanna J; van der Kruijssen, Dave E W; van Rooijen, Karlijn; Linders, Theodora C; Delis-van Diemen, Pien; Alkemade, Maartje; Bolijn, Anne; Tijssen, Marianne; Lemmens, Margriet; Meiqari, Lana; Ketelaars, Steven L C; Closa-Mosquera, Adria; van Dongen, Miranda M W; Lanfermeijer, Mirthe; Lissenberg-Witte, Birgit I; Bosch, Linda J W; Bisschop-Snetselaar, Teunise; Adriaans, Bregje C; Greer, Amy; Riley, David; White, James R; Greco, Christopher; Cox, Liam; Fox, Jesse; Victor, Kaitlin; Leech, Catherine; Angiuoli, Samuel V; Kok, Niels F M; Punt, Cornelis J A; van den Broek, Daan; Koopman, Miriam; Meijer, Gerrit A; Velculescu, Victor E; Roodhart, Jeanine M L; Coupé, Veerle M H; Sausen, Mark; Vink, Geraldine R; Fijneman, Remond J A

Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers

肿瘤断裂负荷量化了与结构变异相关的基因组不稳定性,具有跨癌症的生物学和临床意义。

Lakbir, Soufyan; de Wit, Renske; de Bruijn, Ino; Kundra, Ritika; Madupuri, Ramyasree; Gao, Jianjiong; Schultz, Nikolaus; Meijer, Gerrit A; Heringa, Jaap; Fijneman, Remond J A; Abeln, Sanne

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology

关于肿瘤预测性、预后性和连续性生物标志物检测成本效益分析的建议

Kramer, Astrid; van Schaik, Lucas F; van den Broek, Daan; Meijer, Gerrit A; Gutierrez Ibarluzea, Iñaki; Galnares Cordero, Lorea; Fijneman, Remond J A; Ligtenberg, Marjolijn J L; Schuuring, Ed; van Harten, Wim H; Coupé, Veerle M H; Retèl, Valesca P

CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness

基于循环肿瘤DNA(CtDNA)指导的III期结肠癌辅助化疗降阶治疗:早期基于模型的成本效益评估

Wang, Haoyue; Kramer, Astrid; Greuter, Marjolein J E; Rubio-Alarcón, Carmen; Lissenberg-Witte, Birgit; Meijer, Gerrit A; Kok, Niels F M; van den Broek, Daan; Vink, Geraldine R; Roodhart, Jeanine M L; Sausen, Mark; Fijneman, Remond J A; Coupé, Veerle M H

BLOODPAC's collaborations with European Union liquid biopsy initiatives

BLOODPAC与欧盟液体活检计划的合作

Dickey, Jennifer; Katrivanos, Elaine; Leiman, Lauren C; Abukhdeir, Abde M; Cardone, Antonella; Saritas-Yildirim, Banu; Galamba, Carlos; Jankiewicz, Cheyenne; Rolfo, Christian; Bhandari, Deepshikha; Finnegan, Emily; Fenizia, Francesca; Celik, Haydar; Mehlhorn, Ingrid; Walker, Jillian; Costa, Jose Luis; Williams, Kathy; Sewart, Mark; Olsen, Matias; Wierzba, Michael; Sanzone, Pia; Fijneman, Remond J A; Dumanois, Robert; Mbella, Valerie; Gonzales, Veronica

Cancer treatment monitoring using cell-free DNA fragmentomes

利用无细胞DNA片段组进行癌症治疗监测

Iris van 't Erve # ,Bahar Alipanahi # ,Keith Lumbard # ,Zachary L Skidmore # ,Lorenzo Rinaldi ,Laurel K Millberg ,Jacob Carey ,Bryan Chesnick ,Stephen Cristiano ,Carter Portwood ,Tony Wu ,Erica Peters ,Karen Bolhuis ,Cornelis J A Punt ,Jennifer Tom ,Peter B Bach ,Nicholas C Dracopoli ,Gerrit A Meijer ,Robert B Scharpf ,Victor E Velculescu ,Remond J A Fijneman ,Alessandro Leal

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology

一项情景构建研究,旨在探索循环肿瘤DNA检测在肿瘤学领域未来潜在的实施路径

Kramer, Astrid; Rubio-Alarcón, Carmen; van den Broek, Daan; Vessies, Daan C L; Van't Erve, Iris; Meijer, Gerrit A; Vink, Geraldine R; Schuuring, Ed; Fijneman, Remond J A; Coupé, Veerle M H; Retèl, Valesca P